NBTX · NASDAQ · Biotechnology

Nanobiotix (ADR)

Develops radiotherapy-activated nanoparticle candidates for solid tumors.

$40.83
After-hours close−0.25 (−0.61%)
At close$41.08(−9.03%)
DateEstimateReportedSurprise
Sep 2026−$0.15
Mar 2026$0.30−$0.46−250.7%
Sep 2025−$0.25−$0.13+45.9%
Apr 2025−$0.62−$1.01−63.5%
Nov 2024−$0.51−$0.50+2.5%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Apr 2024
Nov 2023
Mar 2023
Nov 2022
Mar 2022
Aug 2021
May 2021
Oct 2020
Apr 2020
Jun 2019
Dec 2018
Jun 2018
Dec 2017
Jun 2017
Dec 2016
Jun 2016
Dec 2015
Jun 2015
Dec 2014
Jun 2014
Dec 2013
Jun 2013
Dec 2012
Jun 2012
Dec 2011
Jun 2011
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Sep 29, 2026−$0.15$27.3M
Mar 31, 2026$0.30−$0.46−250.7%$51.5M$3.5M−93.2%
Sep 30, 2025−$0.25−$0.13+45.9%$23.9M$31.4M+31.2%
Apr 2, 2025−$0.62−$1.01−63.5%$3.6M−$21.6M−709.2%
Nov 12, 2024−$0.51−$0.50+2.5%$10.3M$10.0M−3.5%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Apr 24, 2024
Nov 13, 2023
Mar 28, 2023
Nov 9, 2022
Mar 30, 2022
Aug 9, 2021
May 5, 2021
Oct 23, 2020
Apr 30, 2020
Jun 30, 2019
Dec 31, 2018
Jun 30, 2018
Dec 31, 2017
Jun 30, 2017
Dec 31, 2016
Jun 30, 2016
Dec 31, 2015
Jun 30, 2015
Dec 31, 2014
Jun 30, 2014
Dec 31, 2013
Jun 30, 2013
Dec 31, 2012
Jun 30, 2012
Dec 31, 2011
Jun 30, 2011